1. Baldessarini RJ (1979) The “neuroleptic” antipsychotic drugs 2. Neurologic side effects. Postgrad Med 65:108–128
2. Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 387–445
3. Beninger RJ, Mason ST, Phillips AG, Fibiger HC (1980) The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J Pharmacol Exp Ther 213:623–627
4. Berger PA, Elliot GR, Barchas JD (1978) Neuroregulators and schizophrenia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1071–1082
5. Costall B, Naylor RJ (1975) Detection of the neuroleptic properties of clozapine, sulpiride, and thioridazine. Psychopharmacologia 43:69–74